Australia's first 3-D printed spine implant
RMIT University in Melbourne has worked with a medical device company and a neurosurgeon to successfully create a 3D printed vertebral cage for a patient with severe back pain.
Nov 19, 2015
0
9
RMIT University in Melbourne has worked with a medical device company and a neurosurgeon to successfully create a 3D printed vertebral cage for a patient with severe back pain.
Nov 19, 2015
0
9
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a ...
Nov 18, 2015
0
3
As the United States and 11 other countries conclude negotiations on the Trans-Pacific Partnership (TPP) trade agreement, we welcome reports that a proposal offered this week would protect the rights of participating nations ...
Oct 8, 2015
0
10
Talc, a substance commonly used in a number of manufacturing processes, including many in the food processing industry, is a health hazard and exposure to it should be closely monitored, say researchers from The Netherlands.
Sep 28, 2015
0
7
Anti-addiction activists are calling on a Senate committee to release findings from a 3-year-old investigation into links between painkiller manufacturers and nonprofit medical groups.
Sep 16, 2015
0
9
A World Health Organization adviser is calling for the government to stop food manufacturers and distributors producing and selling unhealthy, cheap, salty junk food.
Sep 11, 2015
0
20
Food manufacturers must be more vigilant about keeping their operations clean under new government safety rules released Thursday in the wake of deadly foodborne illness outbreaks linked to ice cream, caramel apples, cantaloupes ...
Sep 10, 2015
0
3
Secukinumab (trade name: Cosentyx) has been approved since January 2015 for adults with moderate to severe plaque psoriasis. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment ...
Sep 8, 2015
0
2
All was quiet Wednesday at a GlaxoSmithKline pharmaceutical plant that was shut down after the drug maker discovered the bacteria that cause potentially fatal Legionnaires' disease in a cooling tower at the site.
Aug 12, 2015
0
10
Drugmaker GlaxoSmithKline shut down a plant Tuesday that produces inhaled medications after discovering the bacteria that causes Legionnaire's disease, a potentially fatal form of pneumonia.
Aug 11, 2015
0
6